Table 3 Patients’ characteristics
Parameter | N (%) |
|---|---|
N° of patients | 49 |
Age at diagnosis (years) | |
Median (min-max) | 49 (29-76) |
Menopausal status | 24 (49.0) |
HER2 status | |
0 | 41 (83.7) |
1+ | 6 (12.2) |
2+SISHa/FISHb not amplified | 2 (4.1) |
Chemotherapy Regimens | |
Antracycline+Taxanes | 33 (67.3) |
Antracylcine+Taxanes+Carboplatinum | 16 (32.7) |
TRF2 IRS c categories | |
TRF2Low | 12 (24.5) |
TRF2High | 37 (75.5) |
Ki-67 pre neo-adjuvant | |
Median (min-max) in % | 60 (12-95) |
pCRd | |
Yes | 18 (36.7) |
No | 31 (63.3) |
Median duration of chemotherapy(months) | 5 (2*-8) |
Progressive patients | 12 (25.0) |
No progressive patients | 36 (75.0) |
Overall Survival | |
Death | 8 (16.7) |
Alive | 40 (83.3) |